Arix Bioscience (LSE:ARIX) ROE % Adjusted to Book Value : 19.87% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience ROE % Adjusted to Book Value?

Arix Bioscience's ROE % for the quarter that ended in Jun. 2023 was 10.73%. Arix Bioscience's PB Ratio for the quarter that ended in Jun. 2023 was 0.54. Arix Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 was 19.87%.

Arix Bioscience ROE % Adjusted to Book Value Historical Data

The historical data trend for Arix Bioscience's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience ROE % Adjusted to Book Value Chart

Arix Bioscience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

21.33

-41.56

52.34

-33.76

-18.79

Arix Bioscience Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial								-30.78	-27.21	-39.51	3.59	19.87

Competitive Comparison of Arix Bioscience's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Arix Bioscience's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arix Bioscience's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arix Bioscience's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Arix Bioscience's ROE % Adjusted to Book Value falls into.

Arix Bioscience ROE % Adjusted to Book Value Calculation

Arix Bioscience's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2022 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-11.46%	/	0.61
	=	-18.79%

Arix Bioscience's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	10.73%	/	0.54
	=	19.87%

Arix Bioscience ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Arix Bioscience (LSE:ARIX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Duke Street, Duke Street House, London, GBR, W1K 6JL

Website

https://www.arixbioscience.com

Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines